167 related articles for article (PubMed ID: 11351300)
21. Allelic imbalance in chromosome band 18q21 and SMAD4 mutations in ovarian cancers.
Takakura S; Okamoto A; Saito M; Yasuhara T; Shinozaki H; Isonishi S; Yoshimura T; Ohtake Y; Ochiai K; Tanaka T
Genes Chromosomes Cancer; 1999 Mar; 24(3):264-71. PubMed ID: 10451707
[TBL] [Abstract][Full Text] [Related]
22. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas.
MacGrogan D; Pegram M; Slamon D; Bookstein R
Oncogene; 1997 Aug; 15(9):1111-4. PubMed ID: 9285566
[TBL] [Abstract][Full Text] [Related]
23. Involvement of mutations in the DPC4 promoter in endometrial carcinoma development.
Zhou Y; Kato H; Shan D; Minami R; Kitazawa S; Matsuda T; Arima T; Barrett JC; Wake N
Mol Carcinog; 1999 May; 25(1):64-72. PubMed ID: 10331746
[TBL] [Abstract][Full Text] [Related]
24. No SMAD4 hypermethylation in colorectal cancer.
Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development.
Haines J; Dunford R; Moody J; Ellender M; Cox R; Silver A
Genes Chromosomes Cancer; 2000 Aug; 28(4):387-94. PubMed ID: 10862047
[TBL] [Abstract][Full Text] [Related]
26. Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21.
Yokota T; Matsumoto S; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Jpn J Cancer Res; 1997 Oct; 88(10):959-64. PubMed ID: 9414657
[TBL] [Abstract][Full Text] [Related]
27. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
[TBL] [Abstract][Full Text] [Related]
28. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
29. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.
Görtz B; Roth J; Krähenmann A; de Krijger RR; Muletta-Feurer S; Rütimann K; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
Am J Pathol; 1999 Feb; 154(2):429-36. PubMed ID: 10027401
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability and allelic losses in neuroendocrine tumors of the gastro-entero-pancreatic system.
Ghimenti C; Lonobile A; Campani D; Bevilacqua G; Caligo MA
Int J Oncol; 1999 Aug; 15(2):361-6. PubMed ID: 10402248
[TBL] [Abstract][Full Text] [Related]
31. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
[TBL] [Abstract][Full Text] [Related]
32. Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.
Hua Z; Zhang YC; Hu XM; Jia ZG
World J Gastroenterol; 2003 Dec; 9(12):2764-7. PubMed ID: 14669329
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma.
Heinmöller E; Dietmaier W; Zirngibl H; Heinmöller P; Scaringe W; Jauch KW; Hofstädter F; Rüschoff J
Am J Pathol; 2000 Jul; 157(1):83-92. PubMed ID: 10880379
[TBL] [Abstract][Full Text] [Related]
34. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.
Hahn SA; Schutte M; Hoque AT; Moskaluk CA; da Costa LT; Rozenblum E; Weinstein CL; Fischer A; Yeo CJ; Hruban RH; Kern SE
Science; 1996 Jan; 271(5247):350-3. PubMed ID: 8553070
[TBL] [Abstract][Full Text] [Related]
35. DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors.
Perren A; Saremaslani P; Schmid S; Bonvin C; Locher T; Roth J; Heitz PU; Komminoth P
Diagn Mol Pathol; 2003 Dec; 12(4):181-6. PubMed ID: 14639103
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of Smad4 in gastric carcinomas.
Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW
Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080
[TBL] [Abstract][Full Text] [Related]
37. Different patterns of 11q allelic losses in digestive endocrine tumors.
D'adda T; Pizzi S; Azzoni C; Bottarelli L; Crafa P; Pasquali C; Davoli C; Corleto VD; Delle Fave G; Bordi C
Hum Pathol; 2002 Mar; 33(3):322-9. PubMed ID: 11979373
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the DPC4 gene in gastric carcinoma.
Nishizuka S; Tamura G; Maesawa C; Sakata K; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
Jpn J Cancer Res; 1997 Apr; 88(4):335-9. PubMed ID: 9197522
[TBL] [Abstract][Full Text] [Related]
39. Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas.
Kytölä S; Nord B; Elder EE; Carling T; Kjellman M; Cedermark B; Juhlin C; Höög A; Isola J; Larsson C
Genes Chromosomes Cancer; 2002 Jul; 34(3):325-32. PubMed ID: 12007193
[TBL] [Abstract][Full Text] [Related]
40. Loss of SMAD4 function in small intestinal adenocarcinomas: comparison of genetic and immunohistochemical findings.
Bläker H; Aulmann S; Helmchen B; Otto HF; Rieker RJ; Penzel R
Pathol Res Pract; 2004; 200(1):1-7. PubMed ID: 15157044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
